Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma

Aarati Ranganathan, Alex Adjei, Primo Lara

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma'. Together they form a unique fingerprint.